Checkpoint Therapeutics

YTD

ALL

Why Robinhood?

You can watch CKPT and buy or sell other stocks, ETFs, and their options commission-free!

About CKPT

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX.

CEO

James F. Oliviero, III, CFA

CEOJames F. Oliviero, III, CFA

Employees

Employees24

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2014

Founded2014

Employees

Employees24

CKPT Key Statistics

Market cap

370.71M

Market cap370.71M

Price-Earnings ratio

-3.78

Price-Earnings ratio-3.78

Dividend yield

—

Dividend yield—

Average volume

2.90M

Average volume2.90M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$4.49

52 Week high$4.49

52 Week low

$1.80

52 Week low$1.80

People also own

Based on the portfolios of people who own CKPT. This list is generated using Robinhood data, and it’s not a recommendation.